Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Vivus Puts Obesity Drug On A Diet
TheStreet.com
Tuesday, May 3, 2011 - 9:02am
tags:
Vivus, obesity, Qnexa
Mylan Lawsuit Over Ranbaxy’s Lipitor Copy Thrown Out by Judge
Bloomberg
Tuesday, May 3, 2011 - 9:01am
tags:
Mylan, lawsuits, Ranbaxy, Lipitor, Pfizer, generics
Pfizer Profit Beats Analysts' Estimates on Lower Costs
Bloomberg
Tuesday, May 3, 2011 - 8:59am
tags:
Pfizer, earnings
Teva Pharma Is ‘Ideal Partner,’ Mesoblast CEO Itescu Says
Bloomberg
Tuesday, May 3, 2011 - 7:28am
tags:
Teva Pharmaceuticals, Mesoblast
The Spectrum of Biotech Valuations
Motley Fool
Tuesday, May 3, 2011 - 7:27am
tags:
Spectrum Pharmaceuticals
AstraZeneca decides not to exercise option to license Targacept potential schizophrenia drug
Yahoo/AP
Tuesday, May 3, 2011 - 7:26am
tags:
AstraZeneca, Targacept, schizophrenia
Vivus halves first-quarter loss
Bizjournals.com
Tuesday, May 3, 2011 - 7:15am
tags:
earnings, Vivus
Bristol-Myers recalls Coumadin blood thinner
Yahoo/AP
Tuesday, May 3, 2011 - 7:14am
tags:
recalls, Coumadin, blood thinners, Bristol-Myers Squibb
Revenues Rise at Shire
Yahoo/Zacks.com
Tuesday, May 3, 2011 - 7:05am
tags:
earnings, Shire
Loss narrows at Array BioPharma
Bizjournals.com
Tuesday, May 3, 2011 - 7:04am
tags:
earnings, Array Biopharma
Lilly, Boehringer Win FDA Approval for Type 2 Diabetes Drug
Bloomberg
Monday, May 2, 2011 - 7:21pm
tags:
Eli Lilly, FDA, diabetes, type 2 diabetes, Boehringer Ingelheim, linagliptin
Would a Pfizer Break-Up Leave a Healthier Core?
Motley Fool
Monday, May 2, 2011 - 7:17pm
tags:
Pfizer
Keryx says more EU kidney drug trials unneeded
Yahoo/AP
Monday, May 2, 2011 - 7:16pm
tags:
Europe, kidney cancer, Keryx, Zerenex
Novartis: We're paying for reform without seeing benefits
CNN/Fortune
Monday, May 2, 2011 - 7:13pm
tags:
Novartis, healthcare reform, Joe Jimenez
Select Stem Cell Stocks Surge After Favorable Court Ruling
Yahoo/IndieResearch
Monday, May 2, 2011 - 12:51pm
tags:
stem cells, Arthersys, Neuralstem, Aastrom, Geron, NeoStem, Pleurostem, Osiris
Biotech Calendar: Key Dates for May
Seeking Alpha
Monday, May 2, 2011 - 12:42pm
tags:
biotech, Columbia Laboratories, KV Pharmaceutical, Dendreon, Vertex Pharmaceuticals, MannKind, Alimera, Merck, NPS Pharmaceuticals, Ironwood, BioMimetic Therapeutics, Lexicon Pharmaceuticals, Avanir, Optimer, JNJ
Seattle Genetics says FDA will make two rulings on its cancer drug brentuximab by Aug. 30
Yahoo/AP
Monday, May 2, 2011 - 12:39pm
tags:
FDA, brentuximab vedotin, Seattle Genetics, Hodgkin's lymphoma
Loss Narrows at InterMune
Yahoo/Zacks.com
Monday, May 2, 2011 - 12:38pm
tags:
earnings, InterMune
How Teva, Cephalon compare
Yahoo/AP
Monday, May 2, 2011 - 12:37pm
tags:
Teva Pharmaceuticals, Cephalon, M&A
Loss Widens at Cell Therapeutics
Yahoo/Zacks.com
Monday, May 2, 2011 - 12:36pm
tags:
earnings, Cell Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.